Market watchers, throughout the week, observed several Wall Street executives stepping up for new roles as part of leadership reshuffling.

Meanwhile, some companies such as Biogen, U.S. Bancorp and Western Midstream Partners added new positions to steer growth prospects.

Here are some of the recent management changes that took place during the week:

Biogen (NASDAQ:BIIB) said its Executive Vice President and CFO, Michael McDonnell, plans to retire from the company on Feb. 28, 2025. Upon McDonnell’s retirement, Robin Kramer, currently Chief Accounting Officer at Biogen, will assume the role of CFO.

U.S. Bancorp (NYSE:USB) said its CFO, John Stern, will report directly to Chairman and CEO Andy Cecere, effective immediately. It will also create a new leadership structure for its payments and money movement businesses, as it prepares for the planned retirement of Vice Chair Shailesh Kotwal in H1 2025.

Western Midstream Partners (NYSE:WES) said that it’s appointed board member Oscar Brown as its new President and CEO, succeeding Michael Ure, effective immediately.

Novocure (NVCR) said it has appointed Moderna (MRNA) executive Christoph Brackmann as its next finance chief. Brackmann will join Novocure immediately as a Senior Financial Advisor and will transition to the role of CFO on January 1, 2025.

Planet Fitness (PLNT) has appointed Jay Stasz as its next CFO, effective Nov. 15, 2024.

Silicon Motion Technology (SIMO) said that following a search process, Jason Tsai, currently the interim CFO and VP of Investor Relations and Finance of the company, has been appointed the CFO, effective Oct. 28, 2024.

Stepan (SCL) said it has appointed Luis Rojo as CEO and president, effective immediately.